Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan 24;7(2):283-284.
doi: 10.1182/bloodadvances.2022009192.

DOACs in patients with brain cancers: promising but still a long way to go

Michela Giustozzi  1 , Cecilia Becattini  1 , Fausto Roila  2 , Giancarlo Agnelli  1 , Mario Mandalà  2
Affiliations
Comment

DOACs in patients with brain cancers: promising but still a long way to go

Michela Giustozzi et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
Risk of ICH in patients with primary and metastatic brain cancers treated with DOACs vs LMWH in the updated meta-analysis.
See this image and copyright information in PMC

Comment on

References

    1. Giustozzi M, Proietti G, Becattini C, Roila F, Agnelli G, Mandalà M. ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis. Blood Adv. 2022;6(16):4873–4883. - PMC - PubMed
    1. Carney BJ, Uhlmann EJ, Puligandla M, et al. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. J Thromb Haemost. 2019;17(1):72–76. - PubMed
    1. Reed-Guy L, Desai AS, Phillips RE, et al. Risk of intracranial hemorrhage with direct oral anticoagulants versus low molecular weight heparin in glioblastoma: A retrospective cohort study. Neuro Oncol. 2022 doi: 10.1093/neuonc/noac125. noac125. - DOI - PMC - PubMed
    1. Swartz AW, Drappatz J. Safety of direct oral anticoagulants in central nervous system malignancies. Oncologist. 2021;26(5):427–432. doi: 10.1002/onco.13698. - DOI - PMC - PubMed